Your browser doesn't support javascript.
loading
Molecular tracing of SARS-CoV-2 in Italy in the first three months of the epidemic
Alessia Lai; Annalisa Bergna; Sara Caucci; Nicola Clementi; Ilaria Vicenti; Filippo Dragoni; Anna Maria Cattelan; Stefano Menzo; Angelo Pan; Annapaola Callegaro; Adriano Tagliabracci; Arnaldo Caruso; Francesca Caccuri; Silvia Ronchiadin; Claudia Balotta; Maurizio Zazzi; Emanuela Vaccher; Massimo Clementi; Massimo Galli; Gianguglielmo Zehender.
Afiliação
  • Alessia Lai; Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy.
  • Annalisa Bergna; Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy.
  • Sara Caucci; Department of Biomedical Sciences and Public Health, Virology Unit, Polytechnic University of Marche, Ancona, Italy.
  • Nicola Clementi; Microbiology and Virology Unit, "Vita-Salute" San Raffaele University, Milan, Italy.
  • Ilaria Vicenti; Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Filippo Dragoni; Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Anna Maria Cattelan; Infectious Diseases Unit, Department of Internal Medicine, Azienda Ospedaliera-Universitaria di Padova, Padua, Italy.
  • Stefano Menzo; Department of Biomedical Sciences and Public Health, Virology Unit, Polytechnic University of Marche, Ancona, Italy
  • Angelo Pan; Infectious Diseases, ASST Cremona, Cremona (MI), Italy.
  • Annapaola Callegaro; Microbiology and Virology Laboratory, ASST Papa Giovanni XXIII, Bergamo, Italy
  • Adriano Tagliabracci; Section of Legal Medicine, Polytechnic University of Marche, Ancona, Italy
  • Arnaldo Caruso; Microbiology Unit, Department of Molecular and Translational Medicine, University of Brescia and ASST Spedali Civili Hospital, Brescia, Italy
  • Francesca Caccuri; Microbiology Unit, Department of Molecular and Translational Medicine, University of Brescia and ASST Spedali Civili Hospital, Brescia, Italy
  • Silvia Ronchiadin; Intesa Sanpaolo Innovation Center, AI LAB, Turin, Italy
  • Claudia Balotta; Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy.
  • Maurizio Zazzi; Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Emanuela Vaccher; Medical Oncology and Immune-related Tumors, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano 33081, Italy.
  • Massimo Clementi; Microbiology and Virology Unit, "Vita-Salute" San Raffaele University, Milan, Italy.
  • Massimo Galli; Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy.
  • Gianguglielmo Zehender; Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy.
Preprint em Inglês | medRxiv | ID: ppmedrxiv-20147140
Artigo de periódico
Um artigo publicado em periódico científico está disponível e provavelmente é baseado neste preprint, por meio do reconhecimento de similaridade realizado por uma máquina. A confirmação humana ainda está pendente.
Ver artigo de periódico
ABSTRACT
The aim of this study is the characterization and genomic tracing by phylogenetic analyses of 59 new SARS-CoV-2 Italian isolates obtained from patients attending clinical centres in North and Central Italy until the end of April 2020. All but one of the newly characterized genomes belonged to the lineage B.1, the most frequently identified in European countries, including Italy. Only a single sequence was found to belong to lineage B. A mean of 6 nucleotide substitutions per viral genome was observed, without significant differences between synonymous and non-synonymous mutations, indicating genetic drift as a major source for virus evolution. tMRCA estimation confirmed the probable origin of the epidemic between the end of January and the beginning of February with a rapid increase in the number of infections between the end of February and mid-March. Since early February, an effective reproduction number (Re) greater than 1 was estimated, which then increased reaching the peak of 2.3 in early March, confirming the circulation of the virus before the first COVID-19 cases were documented. Continuous use of state-of-the-art methods for molecular surveillance is warranted to trace virus circulation and evolution and inform effective prevention and containment of future SARS-CoV-2 outbreaks.
Licença
cc_by_nc_nd
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Estudo prognóstico Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Estudo prognóstico Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
...